B Lymphocyte stimulator (BLyS) and monocytes: Possible role in autoimmune diseases with a particular reference to rheumatoid arthritis;Stimolatore B cellulare (BLyS) e monociti: Possibile ruolo nelle malattie autoimmuni ed in particolare nell'artrite reumatoide

Reumatismo

Volumn 56, Issue 3, 2004, Pages 143-146

  Quartuccio, L ^a   Fabris, M ^a   Ferraccioli, Gianfranco ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

B cells; BLyS; Monocytes; Rheumatoid arthritis

Indexed keywords

PROTEIN BLYS; TUMOR NECROSIS FACTOR DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHROPATHY; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; BONE MARROW CELL; CELL INTERACTION; CELL POPULATION; CHRONIC DISEASE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE MARKER; DRUG TARGETING; HOMEOSTASIS; IMMUNOSTIMULATION; LIFESPAN; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; REVIEW; RHEUMATOID ARTHRITIS; SYNOVITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; EDEMA; HUMANS; JOINTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, INBRED MRL LPR; MICE, INBRED NZB; MONOCYTES; MULTIGENE FAMILY; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4744349043     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Liossis SN, Kovacs B, Dennis G, Kammer GM, Tsokos GC. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. J Clin Invest 1996; 98: 2549-57.
2. Mariette X. Gougerot-Sjögren syndrome. Risk of lymphoma. Presse Med 1999; 28: 1214-8.
3. Panayi GS. T-cell-dependent pathways in rheumatoid arthritis. Curr Opin Rheumatol 1997; 9: 236-40.
4. Lanchbury JS. The HLA association with rheumatoid arthritis. Clin Exp Rheum 1992; 10: 301-9.
5. Stiehl P. Histopathological classification of synovial membranes of patients with rheumatoid arthritis. In: Surgical Pathology Update 2001-18th European Congress of Pathology. ABW, Berlin: 281-3.
6. Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, et al. BLyS: a member of the tumor necrosis factor family and B lymphocyte stimulator. Science 1999; 285: 260-3.
7. Mukhopadhyay A, Ni J, Zhai Y, Yu GL, Aggarwal BB. Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J Biol Chem 1999; 274: 15978-81.
8. Von Bulow GU, van Deursen JM, Bram RJ. Regulation of the T-independent humoral response by TACI. Immunity 2001; 14: 573-82.
9. Marsters SA, Yan M, Pitti RM, Haas PE, Dixit VM, Ashkenazi A. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol 2000; 10: 785-8.
10. Nardelli B, Belvedere O, Roschke V, Moore PA, Olsen HS, Migone TS, et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 2001; 97: 198-204.
11. Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999; 190: 1697-710.
12. Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J Clin Invest 2002; 109: 59-68.
13. Gross JA, Dillon SR, Mudri S, Johnston J, Littau A, Roque R, et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking BlyS. Immunity 2001; 15: 289-302.
14. Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000; 404: 995-9.
15. Wang H, Marsters SA, Baker T, Chan B, Lee WP, Fu L, et al. TACI-ligand interactions are required for cell activation and collagen-induced arthritis in mice. Nature Immunology 2001; 2: 632-7.
16. Dorner T, Putterman C. B cell, BAFF/zTNF4, TACI, and systemic lupus erythematosus. Arthritis Res 2001; 3: 197-9.
17. Stohl W. Systemic lupus erithematosus: a BLySsless disease of too much BLyS protein. Curr Opin Rheumatol 2002; 14: 522-8.
18. Mariette X. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome. Ann Rheum Dis 2003; 62: 168-71.
19. o72 presentato al 40° Congresso Nazionale della Società Italiana di Reumatologia (SIR).
20. Mackay F, Schneider P, Rennert P, Browning J. BAFF and APRIL: a tutorial on B cell survival. Ann Rev Immunol 2003; 21: 231-26.
21. Batten M, Groom J, Cachero TG, Qian F, Schneider P, Tschopp J, et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 2000; 192: 1453-66.
22. Martin F, Kearney JF. Marginal-zone B cells. Nat Rev Immunol 2002; 2: 323-35.
23. Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2002; 2: 465-75.
24. Smith HS, Cancro MP. Integrating B cell homeostasis and selection with BLyS. Arch Immmunol Ther Exp 2003; 51: 209-18.